DK0870036T3 - Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor - Google Patents

Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor

Info

Publication number
DK0870036T3
DK0870036T3 DK96938846T DK96938846T DK0870036T3 DK 0870036 T3 DK0870036 T3 DK 0870036T3 DK 96938846 T DK96938846 T DK 96938846T DK 96938846 T DK96938846 T DK 96938846T DK 0870036 T3 DK0870036 T3 DK 0870036T3
Authority
DK
Denmark
Prior art keywords
acetylglucosaminidase
encoding
genetic sequences
mammalian alpha
synthetic mammalian
Prior art date
Application number
DK96938846T
Other languages
English (en)
Inventor
John Joseph Hopwood
Hamish Steele Scott
Birgit Weber
Lianne Blanch
Donald Stewart Anson
Original Assignee
Womens & Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Womens & Childrens Hospital filed Critical Womens & Childrens Hospital
Application granted granted Critical
Publication of DK0870036T3 publication Critical patent/DK0870036T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0105Alpha-N-acetylglucosaminidase (3.2.1.50)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK96938846T 1995-11-23 1996-11-22 Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor DK0870036T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN6748A AUPN674895A0 (en) 1995-11-23 1995-11-23 Synthetic mammalian alpha-N-acetylglucosaminidase and genetic sequences encoding same
PCT/AU1996/000747 WO1997019177A1 (en) 1995-11-23 1996-11-22 SYNTHETIC MAMMALIAN α-N-ACETYLGLUCOSAMINIDASE AND GENETIC SEQUENCES ENCODING SAME

Publications (1)

Publication Number Publication Date
DK0870036T3 true DK0870036T3 (da) 2008-11-24

Family

ID=3791070

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96938846T DK0870036T3 (da) 1995-11-23 1996-11-22 Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor

Country Status (10)

Country Link
US (3) US6255096B1 (da)
EP (2) EP2048235A3 (da)
JP (1) JP2000500972A (da)
AT (1) ATE411390T1 (da)
AU (1) AUPN674895A0 (da)
DE (1) DE69637715D1 (da)
DK (1) DK0870036T3 (da)
ES (1) ES2319828T3 (da)
PT (1) PT870036E (da)
WO (1) WO1997019177A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2400634A1 (en) * 2000-02-17 2001-08-23 Chester Li Genetic modification of the lung as a portal for gene delivery
US9273300B2 (en) * 2007-02-07 2016-03-01 Strike Bio, Inc Methods and compositions for modulating sialic acid production and treating hereditary inclusion body myopathy
WO2009131698A2 (en) * 2008-04-23 2009-10-29 Iowa State University Research Foundation, Inc. PHOSPHORYLATED RECOMBINANT N-ACETYL-alpha-D- GLUCOSAMINIDASE (NaGlu) AND USES THEREOF
HUE052944T2 (hu) 2010-06-25 2021-05-28 Shire Human Genetic Therapies Terápiás hatóanyagok központi idegrendszerbe juttatása
WO2012012742A2 (en) * 2010-07-22 2012-01-26 Shire Human Genetic Therapies, Inc. Crystal structure of human alpha-n-acetylglucosaminidase
PT2925776T (pt) 2012-11-27 2018-07-30 Biomarin Pharm Inc Proteínas de fusão de enzima lisossomal terapêuticas alvo e suas utilizações
MX2023002346A (es) 2020-08-28 2023-03-22 Japan Chem Res Mutante de a-n-acetilglucosaminidasa.

Also Published As

Publication number Publication date
EP0870036A1 (en) 1998-10-14
WO1997019177A1 (en) 1997-05-29
US20030039643A1 (en) 2003-02-27
EP0870036A4 (en) 2000-01-19
PT870036E (pt) 2009-01-22
ATE411390T1 (de) 2008-10-15
US20070212769A1 (en) 2007-09-13
AUPN674895A0 (en) 1995-12-14
US6255096B1 (en) 2001-07-03
EP2048235A2 (en) 2009-04-15
DE69637715D1 (de) 2008-11-27
US7604958B2 (en) 2009-10-20
ES2319828T3 (es) 2009-05-12
EP2048235A3 (en) 2009-04-22
EP0870036B1 (en) 2008-10-15
JP2000500972A (ja) 2000-02-02

Similar Documents

Publication Publication Date Title
DE69510810T2 (de) Lamanin-ketten: diagnostische und therapeutische verwendung
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
DE69729473D1 (de) Pharmazeutisch-genetische verfahren zur verwendung bei der behandlung von krankheiten des nervensystems
ATE172984T1 (de) Nukleinsäuren-bindende oligomere mit n- verzweigung für therapie und diagnostik
EP1361229A3 (en) Use of Tyrosine Kinase (PYK2) to produce antibodies
DE69628758D1 (de) Identifikation von mutationen, die mit menschlicher alpha-thalassämie assoziiert sind, und ihre verwendung für die vorhersage von blutkrankheiten.
ATE209684T1 (de) Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung
SE8902532D0 (sv) Bestaemning av plasmaproteiner
DE60045681D1 (de) Vaskuläre adhesionsmoleküle und modulierung ihrer funktion
WO1998026054A3 (en) Pyk2 related products and methods
ATE180494T1 (de) Nukleinsäure-bindende oligomere mit c-verzweigung für therapie und diagnostik
DK0870036T3 (da) Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor
CA2099503A1 (en) Synthetic alpha-l-iduronidase and genetic sequences encoding same
ATE113591T1 (de) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
ATE315092T1 (de) Acetylhydrolase des plättchen aktivierenden faktors, und entsprechendes gen
ATE312914T1 (de) Rdgb-proteine
DE69636367D1 (de) T-pa polymorphismus und dessen verwendung zur risikodiagnose von thrombus assoziierten krankheiten
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
ATE247467T1 (de) Neue therapeutische verwendung von 1,6-dimethyl- 8beta-hydroxymethyl-10alpha-methoxyergolin
DE59609836D1 (de) Verwendung von zuckertensiden zur behandlung von ledern und pelzen